Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maren Soft Capsules (麻仁软胶囊) is an approved Traditional Chinese Medicine (TCM) developed and manufactured by Tianjin Central Pharmaceutical. It is formulated as an oral softgel capsule containing a mixture of herbal ingredients, including hemp seed (Cannabis semen / 火麻仁), bitter almond (Armeniacae semen amarum / 苦杏仁), rhubarb (Rhei radix et rhizoma / 大黄), stir-fried citrus fruit (Aurantii fructus immaturus / 枳实), ginger-processed magnolia bark (Magnoliae officinalis cortex / 厚朴), and stir-fried white peony root (Paeoniae radix alba / 白芍). Maren Soft Capsules are primarily indicated for moistening the intestines and promoting bowel movements to relieve constipation, particularly constipation caused by dryness in the intestines or habitual constipation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Maren Soft Capsules.